FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081097 [Registered on: 21/02/2025] Trial Registered Prospectively
Last Modified On: 21/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Agnimukha churna and hamsapadadi vati in the management of subclinical hypothyroidism 
Scientific Title of Study   Efficacy of Agnimukha Churna and Hamsapadadi Vati in the Managememt of Subclinical Hypothyroidism-an open labelled randomized standard controlled clinical trail 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sushmita Ninganure 
Designation  MD Scholar 
Affiliation  Institute of Teaching and Research in Ayurveda, Jmanagar 
Address  Department of Kayachikitsa 4th floor Institute of Teaching and Research in Ayurveda(Institute of National Importance) Ministry of Ayush Government of India Jamnagar-361008

Jamnagar
GUJARAT
361008
India 
Phone  9916806527  
Fax    
Email  sushmitan444@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Charmi S Mehta 
Designation  Lecture 
Affiliation  Institute of Teaching and Research in Ayurveda Jamnagar 
Address  Department of kayachikitsa 4th floor institute building ITRA Jamnagar GUJARAT 361008

Jamnagar
GUJARAT
361008
India 
Phone  9428862264  
Fax    
Email  csmehta@itra.edu.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sushmita Ninganure 
Designation  MD Scholar 
Affiliation  Institute of Teaching and Research in Ayurveda Jamnagar 
Address  Department of Kayachikitsa 4th floor Institute of Teaching and Research in Ayurveda(Institute of National Importance) Ministry of Ayush Government of India Jamnagar-361008

Jamnagar
GUJARAT
361008
India 
Phone  9916806527  
Fax    
Email  sushmitan444@gmail.com  
 
Source of Monetary or Material Support  
Institute of Teaching and Research in Ayurveda (institute of national importance) ministry of Ayush opposite city B division police station gurudwara road jamnagar gujarat 361008 
 
Primary Sponsor  
Name  Institute of Teaching and Research in Ayurveda  
Address  Institute of Teaching and Research in Ayurveda Opposite City B division Police station Gurudwara road Jamnagar 361008 Gujarat India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sushmita Ninganure  PG hospital ITRA Jamnagar  OPD No: 11 Department of Kayachikitsa ITRA Jamnagar, Opposite City B division Police station, Gurudwara road, Jamnagar, 361008
Jamnagar
GUJARAT 
9916806527

sushmitan444@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:E02||Subclinical iodine-deficiency hypothyroidism. Ayurveda Condition: AGNIVAISHAMYAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Agnimukha churna, Reference: ajeerna rogadhikara, vangasena samhita, Route: Oral, Dosage Form: Churna/ Powder, Dose: 6(g), Frequency: bd, Bhaishajya Kal: Pragbhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -koshnajala), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Hamsapadadi vati, Reference: vaidyamanorama, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -koshnajala), Additional Information: -
3Comparator Arm (Non Ayurveda)-Thyroxinetablet thyroxine 1.6mcg/kg body weight OD
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1)Patients aged between 18-60 years of either gender.
2)Newly diagnosed or previously diagnosed patient of TSH level 4.32-10mlU/L.
3)Patients having no symptoms or few symptoms of subclinical hypothyroidism like tiredness, weakness, dry skin, cold intolerance, hair loss, constipation, weight gain with poor appetite, and menstrual abnormalities.
4)Patients willing to participate in the study.
 
 
ExclusionCriteria 
Details  1)Serum TSH level more than 10mIU/L and less than 4.32mIU/L
2)Patient taking allopathic medication for subclinical hypothyroidism.
3)Patients suffering from any other systemic illness viz. with a known case of uncontrolled Diabetes (Random blood sugar more than 200mg/dl), uncontrolled Hypertension (systolic blood pressure more than 140mmHg or diastolic blood pressure more than 90 mmHg), Psychiatric disorders, cardiovascular events, cerebrovascular event, malignancy.
4)Patients suffering from secondary hypothyroidism, Hashimoto’s thyroiditis.
5)Pregnant and lactating patients.
6)Patients aged below 18 years and above 60 years of either sex.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   On-site computer system 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reduction in the serum TSH level  60 days 
 
Secondary Outcome  
Outcome  TimePoints 
a) Improvement in symptoms of subclinical hypothyroidism.
b) Improvement in Agni
c) Improvement in the quality of life (Modified quality of life scale of thyroid)
 
60 days 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   06/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The trial is a randomized standard controlled clinical trial to evaluate the role of Agnimikha churna and hamsapadadi vati in the management of Subclinical Hypothyroidism. A total of 30 patients will be enrolled in the study. Selected patients will be divided into 2 groups based on computer-generated randomization. In one group Agnimukha churna 6gm, twice a day will be given before lunch and dinner with lukewarm water. Hamsapadadi Vati 500mg 2 vati will be given after lunch and dinner for 60 days. In the second group levothyroxine tablet 1.6mcg/kg of body weight will be given empty stomach in the morning for 60 days. Followups will be carried out weekly for 1-month duration. The primary outcome of the study is a reduction in serum TSH levels.  
Close